Clinical Trial Update: Vasodilatory and Metabolic Effects of Glucagon-like Peptide-1 in Periphery Circulation in Patients With and Without Type 2 Diabetes Mellitus [NA]

View source ↗

Summary

A completed clinical trial evaluated the vasodilatory and metabolic effects of glucagon-like peptide-1 in peripheral circulation in people with and without type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• glucagon-like peptide-1 (glucagon-like peptide-1)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Type 2 Diabetes, Blod Pressure | NA | Status: COMPLETED